LHRH Antagonists Schally, Andrew V.; Bajusz, Sandor; The present invention deals with LHRH antagonists which possess improved water http://www.devileye.net/catalog/flat_screen_cathode_including_microtips/lhrh_ant
Extractions: The present invention relates to novel peptides which inhibit the release of gonadotropins by the pituitary gland in mammals without inducing edematous reactions. More specifically, the present invention relates to analogs of the luteinizing hormone releasing hormone (LHRH), which has the structure: For more than 15 years, investigators have been searching for selective, potent antagonists of the LHRH decapeptide (M. Karten and J. E. Rivier, Endocrine Reviews, 7, 44-66 (1986)). The high degree of interest in such antagonists is due to their usefulness in the fields of endocrinology, gynecology, contraception and cancer. A large number of compounds have been prepared as potential LHRH antagonists. The most interesting antagonists to date have been compounds whose structure is a modification of the structure of LHRH. The first series of potent antagonists was obtained by introduction of aromatic acid residues into positions 1, 2, 3 and 6, or, 2, 3, and 6. The compounds are expressed as LHRH modified by replacement of the original amino acid residues by others at the position indicated by the superscript numbers. The known antagonists include:
Medical Scientists-S Schally, Andrew V. Schwann, Theodor Schweitzer, Albert Semmelweis, Ignaz Philipp Servetus, Michael (Miguel Serveto) http://www.cartage.org.lb/en/themes/Biographies/Categories/Technologists/Medical
Follicle-stimulating Hormone — Infoplease.com Andrew V. Schally Schally, Andrew V. Schally, Andrew V., 1926–, American endocrinologist, b. Wilno, Poland (now fertility drug - fertility drug fertility drug, any of a http://www.infoplease.com/ce6/sci/A0913472.html
Hypothalamus — FactMonster.com Andrew V. Schally Schally, Andrew V. Schally, Andrew V., 1926–, American endocrinologist, b. Wilno, Poland (now thyrotropin - thyrotropin thyrotropin or thyroid-stimulating http://www.factmonster.com/ce6/sci/A0824782.html
Extractions: Reference Desk Encyclopedia hypothalamus u u m u s) [ key , an important supervisory center in the brain , rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function. The hypothalamus regulates body temperature, blood pressure, heartbeat, metabolism of fats and carbohydrates, and sugar levels in the blood. Through direct attachment to the pituitary gland , the hypothalamus also meters secretions controlling water balance and milk production in the female. The role of the hypothalamus in awareness of pleasure and pain has been well established in the laboratory. It is thought to be involved in the expression of emotions, such as fear and rage, and in sexual behaviors. Despite its numerous vital functions, the hypothalamus in humans accounts for only 1/300 of total brain weight, and is about the size of an almond. Structurally, it is joined to the thalamus ; the two work together to monitor the sleep-wake cycle.
Andrzej Schally - Wikipédia, A Enciclopédia Livre Schally, Andrew V Schally, Andrew V Schally, Andrew V. Schally, Andrew Victor Schalm classification Schalmei Schalmei schalstein SCHAM Schama Schama Schamberg's disease http://pt.wikipedia.org/?title=Andrew_V._Schally
Andrew Schally Biography Schally, Andrew V(ictor) (1926-) An article from Contemporary Authors. This digital document, covering the life and work of Andrew V(ictor) Schally, is an entry http://andrew-schally.epik.com/
Schalmei - Hutchinson Encyclopedia Article About Schalmei Schally, Andrew V Schally, Andrew V Schally, Andrew V. Schally, Andrew Victor Schalm classification Schalmei schalstein SCHAM Schama Schama Schamberg's disease http://encyclopedia.farlex.com/Schalmei
Kate Groot - Research Profile On BiomedExperts 2005 Keller Gunhild; Schally Andrew V; Groot Kate; Toller Gabor L; Havt Alexandre; K ster Frank; Armatis Patricia; Halmos Gabor; Zarandi Marta; Varga Jozsef L; Engel J rg B http://www.biomedexperts.com/Profile.bme/497861/Kate_Groot
Schalmei Definition Of Schalmei In The Free Online Encyclopedia. Schally, Andrew V Schally, Andrew V Schally, Andrew V. Schally, Andrew Victor Schalm classification Schalmei schalstein SCHAM Schama Schama Schamberg's disease http://encyclopedia2.thefreedictionary.com/Schalmei
Schally, Andrew V. « Polonia Life Seitz, Stephan; Schally, Andrew V.; Treszl, Andrea; Papadia, Andrea; Rick, Ferenc; Szalontay, Luca; Szepeshazi, Karoly; Ortmann, Olaf; Halmos, Gabor; Hohla, Florian; Buchholz http://www.polonialife.ca/polacy/polacy-swiatu/schally-andrew-v/
Extractions: Po wojnie pozostał w Szkocji i tam także Andrzej Schally ukończył szkołę średnia, skąd wyjechał do Londynu na studia chemiczne. Pracę naukową rozpoczął w National Institute of Medical Research. Chyba nie odważyłabym się o Andrzeju pisać, bo na początek zaplanowałam prezentację Polaków pracujących dla wspólnego światowego dziedzictwa, a w jakis sposób związanych także z Kanadą, gdyby nie fakt, że właśnie w Kanadzie, w Montrealu podjął pracę w 1952 roku w charakterze pracownika naukowego na Uniwersytecie McGill i właśnie w Kanadzie (jak sądzę) wykształciły się jego zainteresowania endokrynologią. Endokrynologia jest poddyscypliną medyczną dość młodą, ale ma już wielu entuzjastów wierzących głęboko, że zglębianie tejże pomoże ujawnić procesy dotąd może omijane, może lekceważone, ale z pewnością traktowane po macoszemu.
20th Century Year By Year 1977 SCHALLY, ANDREW V., U.S.A., Veterans Administration Hospital, New Orleans, LA, b. 1926 ( in Wilno, Poland) for their discoveries concerning the peptide hormone production of the http://www.historycentral.com/20th/1977.html
(WO/1995/016707) ANALOGUES OF HGH-RH (1-29)NH 2? HAVING SCHALLY, Andrew, V. US/US; (US) (US Only). ZARANDI, Marta HU/US; (US) (US Only). Inventors SCHALLY, Andrew, V.; (US). ZARANDI, Marta; (US). Agent http://www.wipo.int/pctdb/en/wo.jsp?wo=1995016707
Extractions: Faqs.org homepage Abstracts index Health Article Abstract: author: Monsonego, Joseph, Destable, Marie-Dominique, De Saint Florent, Georges, Amouroux, Jacques, Kouyoumdjian, Jean-Claude, Haour, France, Breau, Jean-Luc, Israel, Lucien, Comaru-Schally, Ana-Maria, Schally, Andrew V. Publisher: Elsevier B.V. Physiological aspects, Statistics, Hormone therapy, Fibrocystic breast disease User Contributions: Comment about this article or add new information about this topic: Comment: (50-4000 characters) Name: E-mail: Security Code: Display my email: Article Abstract: Targeting chemotherapy to the receptor for luteinizing hormone-releasing hormone may reduce its toxicity when used to treat ovarian cancer. This is done by combining the chemotherapy drug with luteinizing hormone-releasing hormone, a naturally occurring hormone in the body. Some types of ovarian cancer have the receptor for luteinizing hormone-releasing hormone on their surface. The targeted chemotherapy would bind to this receptor and the toxic drug would kill the tumor. In a study of mice, the hormone was linked to a chemotherapy drug related to doxorubicin (Adriamycin). This combination inhibited tumor growth with few side effects.
